Real-world clinical outcome related to veno-arterial extracorporeal membranous oxygenator: a single-center experience

9 March 2024 (12:15 - 13:15)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Sanghyup Lee

Yonsei University, Seoul (Korea (Republic of))

7 More presentations in this session

Presentation thumbnail

European practices on antithrombotic management during percutaneous mechanical circulatory support in adults: an international survey of the ACVC Association of the ESC joint with EuroELSO

Doctor C. Van Edom (Leuven, BE)

Abstract Slides

Presentation thumbnail

Echocardiographic evaluation of ventricular performance in VA-ECMO weaning: results from a observational multicentric prospective study

Doctor V. Dammassa (London, GB)

Abstract Slides

Presentation thumbnail

Impact of early administration of beta-blocker and RAS inhibitor during VA-ECMO treatment for cardiogenic shock; the post-hoc study of the EARLY-UNLOAD trial.

Doctor S. Park (Kwang Ju, KR)

Abstract Slides

Presentation thumbnail

Anti-Xa/APTT discrepancy in heparinized ImpellaTM-supported cardiogenic shock patients can predict mortality

Doctor C. Van Edom (Leuven, BE)

Abstract Slides

Presentation thumbnail

Impella vs Veno-arterial extracorporeal membrane oxygenation in cardiogenic shock: a systematic review and meta-analysis of propensity score matched studies

Professor D. Stub (Melbourne, AU)

Abstract Slides

Access the full session

Session thumbnail

Best practices in temporary mechanical circulatory support

The Event

Event poster

ESC Acute CardioVascular Care 2024

9 March 2024 12:15 CET

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources